Publications 2023

Arjona-Sanchez A, Martinez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kepenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F et al. (2023)
External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification
Eur J Surg Oncol, 49 (8), 1481-1488
DOI 10.1016/j.ejso.2023.03.206, PubMed 36935222

Davidson B, Doutel D, Holth A, Nymoen DA (2023)
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Virchows Arch, 482 (6), 975-982
DOI 10.1007/s00428-023-03541-6, PubMed 37067588

Davidson B, Doutel D, Holth A, Nymoen DA (2023)
Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Virchows Arch (in press)
DOI 10.1007/s00428-023-03567-w, PubMed 37261507

Davidson B, Solheim O (2023)
Cancer Stem Cell Markers Are Differentially Expressed in Malignant Ovarian Germ Cell Tumors
Int J Gynecol Pathol (in press)
DOI 10.1097/PGP.0000000000000947, PubMed 37186896

Dos Santos MV, Holth A, Lindemann K, Staff AC, Davidson B (2023)
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma
Gynecol Oncol, 176, 76-81
DOI 10.1016/j.ygyno.2023.07.004, PubMed 37478615

Doutel D, Davidson B, Nitschke Pettersen IK, Torgunrud A (2023)
Molecular characteristics of low-grade serous carcinoma in effusions
Cytopathology, 34 (2), 99-105
DOI 10.1111/cyt.13207, PubMed 36609991

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M, Micci F, Heim S (2023)
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis
Cancer Genomics Proteomics, 20 (4), 363-374
DOI 10.21873/cgp.20388, PubMed 37400148

Publications 2022

Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, Eriksson AGZ, Trent PKB, Heim S, Micci F (2022)
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
Cancers (Basel), 14 (14)
DOI 10.3390/cancers14143536, PubMed 35884597

Davidson B, Elstrand MB (2022)
Clinicopathological prognostic parameters in patients with tubo-ovarian carcinoma effusions
Cytopathology, 33 (4), 479-492
DOI 10.1111/cyt.13126, PubMed 35398934

Gatius S, Velasco A, Varela M, Cuatrecasas M, Jares P, Setaffy L, Bonhomme B, Santon A, Lindemann K, Croce S, Davidson B, Lax S, Palacios J, Matias-Guiu X (2022)
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study
Virchows Arch, 480 (5), 1031-1039
DOI 10.1007/s00428-022-03291-x, PubMed 35124717

Gilks CB, Selinger CI, Davidson B, Köbel M, Ledermann JA, Lim D, Malpica A, Mikami Y, Singh N, Srinivasan R, Vang R, Lax SF, McCluggage WG (2022)
Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
Int J Gynecol Pathol, 41 (Suppl 1), S119-S142
DOI 10.1097/PGP.0000000000000908, PubMed 36305537

Kleinmanns K, Gullaksen SE, Bredholt G, Davidson B, Torkildsen CF, Grindheim S, Bjørge L, McCormack E (2022)
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
Cancers (Basel), 14 (13)
DOI 10.3390/cancers14133092, PubMed 35804867

Onallah H, Mannully ST, Davidson B, Reich R (2022)
Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
Int J Mol Sci, 23 (21)
DOI 10.3390/ijms232113286, PubMed 36362078

Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality
Cancer Genomics Proteomics, 19 (5), 636-646
DOI 10.21873/cgp.20348, PubMed 35985686

Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
Fusion of the HMGA2 and BNC2 Genes in Uterine Leiomyoma With t(9;12)(p22;q14)
In Vivo, 36 (6), 2654-2661
DOI 10.21873/invivo.13000, PubMed 36309352

Sonzini G, Granados-Aparici S, Sanegre S, Diaz-Lagares A, Diaz-Martin J, de Andrea C, Eritja N, Bao-Caamano A, Costa-Fraga N, García-Ros D, Salguero-Aranda C, Davidson B, López-López R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R (2022)
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness
Front Cell Dev Biol, 10, 1052098
DOI 10.3389/fcell.2022.1052098, PubMed 36467415

Van Nyen T, Planque M, van Wagensveld L, Duarte JAG, Zaal EA, Talebi A, Rossi M, Körner PR, Rizzotto L, Moens S, De Wispelaere W, Baiden-Amissah REM, Sonke GS, Horlings HM, Eelen G, Berardi E, Swinnen JV, Berkers CR, Carmeliet P, Lambrechts D, Davidson B, Agami R, Fendt SM, Annibali D, Amant F (2022)
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
Nat Commun, 13 (1), 4578
DOI 10.1038/s41467-022-32272-6, PubMed 35931688

Publications 2021

Andersson Y, Fleten KG, Abrahamsen TW, Reed W, Davidson B, Flatmark K (2021)
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale
Cancers (Basel), 13 (11)
DOI 10.3390/cancers13112819, PubMed 34198773

Davidson B, Kleinberg L, Børresen IM, Slettevoll F, Fangberget A, Hindosh D, Zahl Eriksson AG, Bjerkehagen B (2021)
Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis
Virchows Arch, 479 (2), 419-424
DOI 10.1007/s00428-021-03057-x, PubMed 33595736

Eriksson AGZ, Davidson B, Bjerre Trent P, Eyjólfsdóttir B, Dahl GF, Wang Y, Staff AC (2021)
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
J Clin Med, 10 (14)
DOI 10.3390/jcm10143094, PubMed 34300260

Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM (2021)
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
J Immunother Cancer, 9 (10)
DOI 10.1136/jitc-2021-003109, PubMed 34711663

García de Jalón E, Kleinmanns K, Fosse V, Davidson B, Bjørge L, Haug BE, McCormack E (2021)
Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model
Mol Imaging Biol, 25 (1), 144-155
DOI 10.1007/s11307-021-01685-y, PubMed 34888759

Jacobs Catane L, Moshel O, Smith Y, Davidson B, Reich R (2021)
Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells
Int J Mol Sci, 22 (23)
DOI 10.3390/ijms222312647, PubMed 34884451

Muylaert RL, Davidson B, Ngabirano A, Kalema-Zikusoka G, MacGregor H, Lloyd-Smith JO, Fayaz A, Knox MA, Hayman DTS (2021)
Community health and human-animal contacts on the edges of Bwindi Impenetrable National Park, Uganda
PLoS One, 16 (11), e0254467
DOI 10.1371/journal.pone.0254467, PubMed 34818325

Ruiz de Garibay G, García de Jalón E, Stigen E, Lund KB, Popa M, Davidson B, Safont MM, Rygh CB, Espedal H, Barrett TM, Haug BE, McCormack E (2021)
Repurposing ¹⁸F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy
Theranostics, 11 (12), 6044-6057
DOI 10.7150/thno.55092, PubMed 33897898

Sanegre S, Eritja N, de Andrea C, Diaz-Martin J, Diaz-Lagares Á, Jácome MA, Salguero-Aranda C, García Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R (2021)
Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma
Front Cell Dev Biol, 9, 670185
DOI 10.3389/fcell.2021.670185, PubMed 34150764

Publications 2020

Bixel K, Vetter M, Davidson B, Berchuck A, Cohn D, Copeland L, Fowler JM, Havrilesky L, Lee PS, O'Malley DM, Salani R, Valea F, Alvarez Secord A, Backes F (2020)
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer
Gynecol Oncol, 156 (3), 530-534
DOI 10.1016/j.ygyno.2019.12.016, PubMed 31937450

Broner EC, Onallah H, Re'em TT, Davidson B, Reich R (2020)
Role of the Exosome Secretion Machinery in Ovarian Carcinoma: In Vitro and In Vivo Models
J. Oncol., 2020, 4291827
DOI 10.1155/2020/4291827

Brook I, Cord L, Orestes M, Davidson B (2020)
Swallowing difficulties caused by a voice prosthesis in a laryngectomee
Eur Ann Otorhinolaryngol Head Neck Dis, 137 (5), 411-413
DOI 10.1016/j.anorl.2019.12.014, PubMed 32448709

Brunetti M, Panagopoulos I, Kostolomov I, Davidson B, Heim S, Micci F (2020)
Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
Oncol Lett, 20 (3), 2273-2279
DOI 10.3892/ol.2020.11782, PubMed 32782545

Chehover M, Reich R, Davidson B (2020)
Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
Virchows Arch, 477 (2), 249-258
DOI 10.1007/s00428-019-02737-z, PubMed 31900634

Davidson B (2020)
Molecular testing on serous effusions
Diagn Cytopathol, 49 (5), 640-646
DOI 10.1002/dc.24392, PubMed 32023012

Davidson B, Bock AJ, Holth A, Nymoen DA (2020)
Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma
Cytopathology, 31 (6), 572-578
DOI 10.1111/cyt.12895, PubMed 32741023

Davidson B, Bock AJ, Holth A, Nymoen DA (2020)
The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma
Cytopathology, 32 (2), 161-168
DOI 10.1111/cyt.12921, PubMed 33025675

Davidson B, Holth A, Dong HP (2020)
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
Virchows Arch, 477 (5), 677-685
DOI 10.1007/s00428-020-02850-4, PubMed 32472195

Davidson B, Matias-Guiu X, Lax SF (2020)
The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma
Virchows Arch, 476 (4), 489-490
DOI 10.1007/s00428-020-02762-3, PubMed 31993772

Davidson B, McFadden E, Holth A, Brunetti M, Flørenes VA (2020)
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
Virchows Arch, 477 (6), 857-864
DOI 10.1007/s00428-020-02842-4, PubMed 32533344

Filippov-Levy N, Davidson B, Reich R (2020)
The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma
Anticancer Res, 40 (12), 6677-6684
DOI 10.21873/anticanres.14691, PubMed 33288561

Filippov-Levy N, Reich R, Davidson B (2020)
The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma
Int J Mol Sci, 21 (15)
DOI 10.3390/ijms21155237, PubMed 32718068

Kleinmanns K, Fosse V, Davidson B, de Jalón EG, Tenstad O, Bjørge L, McCormack E (2020)
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
EBioMedicine, 56, 102783
DOI 10.1016/j.ebiom.2020.102783, PubMed 32454402

Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, Coonar A, Hasan J, Davidson B, Marchbank A, Grumett S, Williams NR, Macbeth F, Farewell V, Treasure T (2020)
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed
Colorectal Dis, 22 (10), 1314-1324
DOI 10.1111/codi.15113, PubMed 32388895

Schenck A, Vera-Rodriguez M, Greggains G, Davidson B, Fedorcsák P (2020)
Spatial and temporal changes in follicle distribution in the human ovarian cortex
Reprod Biomed Online, 42 (2), 375-383
DOI 10.1016/j.rbmo.2020.10.013, PubMed 33309389

Shen YA, Hong J, Asaka R, Asaka S, Hsu FC, Suryo Rahmanto Y, Jung JG, Chen YW, Yen TT, Tomaszewski A, Zhang C, Attarwala N, DeMarzo AM, Davidson B, Chuang CM, Chen X, Gaillard S, Le A, Shih IM, Wang TL (2020)
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
Cancer Res, 80 (20), 4514-4526
DOI 10.1158/0008-5472.CAN-19-3971, PubMed 32859605

Publications 2019

Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, Lee CH, Hollfelder N, Corcoran P, Gonzalez-Molina J, Moyano-Galceran L, Bell DA, Schoolmeester JK, Måsbäck A, Kristensen GB, Davidson B, Lehti K, Isaksson A, Carlson JW (2019)
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Clin Cancer Res, 25 (7), 2155-2165
DOI 10.1158/1078-0432.CCR-18-2792, PubMed 30617134

Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F (2019)
Molecular characterization of carcinosarcomas arising in the uterus and ovaries
Oncotarget, 10 (38), 3614-3624
DOI 10.18632/oncotarget.26942, PubMed 31217897

Brunetti M, Panagopoulos I, Micci F, Davidson B (2019)
MGMT promoter methylation is a rare epigenetic change in malignant effusions
Cytopathology, 31 (1), 12-15
DOI 10.1111/cyt.12782, PubMed 31808217

Davidson B (2019)
Biomarkers of drug resistance in ovarian cancer - an update
Expert Rev Mol Diagn, 19 (6), 469-476
DOI 10.1080/14737159.2019.1618187, PubMed 31075061

Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Holth A, Capella G, Davidson B, Evans DG, Martins A, Møller P, Hovig E (2019)
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
Sci Rep, 9 (1), 18555
DOI 10.1038/s41598-019-54517-z, PubMed 31811167

Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2019)
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
Eur J Surg Oncol, 47 (1), 134-138
DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394

Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN (2019)
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
Gynecol Oncol Rep, 30, 100502
DOI 10.1016/j.gore.2019.100502, PubMed 31720357

Latham ADM, Davidson B, Warburton B, Yockney I, Hampton JO (2019)
Efficacy and Animal Welfare Impacts of Novel Capture Methods for Two Species of Invasive Wild Mammals in New Zealand
Animals (Basel), 10 (1)
DOI 10.3390/ani10010044, PubMed 31878314

Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
Cold Spring Harb Mol Case Stud, 5 (2)
DOI 10.1101/mcs.a003566, PubMed 30862609

Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA (2019)
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
Int J Gynecol Pathol, 38 Suppl 1 (Iss 1 Suppl 1), S40-S63
DOI 10.1097/PGP.0000000000000491, PubMed 30550483

Onallah H, Davidson B, Reich R (2019)
Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways
J Oncol, 2019, 7547469
DOI 10.1155/2019/7547469, PubMed 31636669

Sherman-Samis M, Onallah H, Holth A, Reich R, Davidson B (2019)
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma
Gynecol Oncol, 153 (3), 651-660
DOI 10.1016/j.ygyno.2019.03.099, PubMed 30904337

Wohlschlaeger J, Davidson B, Worm K, Feist H, Peters J, Hager T, Schmid KW, Ostertag H (2019)
Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E)
Int J Gynecol Pathol, 38 (5), 459-463
DOI 10.1097/PGP.0000000000000526, PubMed 29851866

Yu Y, Suryo Rahmanto Y, Shen YA, Ardighieri L, Davidson B, Gaillard S, Ayhan A, Shi X, Xuan J, Wang TL, Shih IM (2019)
Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
EBioMedicine, 47, 184-194
DOI 10.1016/j.ebiom.2019.08.055, PubMed 31492560

Publications 2018

Agostini A, Brunetti M, Davidson B, Göran Tropé C, Heim S, Panagopoulos I, Micci F (2018)
Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
Int J Cancer, 143 (6), 1379-1387
DOI 10.1002/ijc.31418, PubMed 29633253

Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ, Heim S, Panagopoulos I, Micci F (2018)
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Sci Rep, 8 (1), 11069
DOI 10.1038/s41598-018-29332-7, PubMed 30038317

Brunetti M, Gorunova L, Davidson B, Heim S, Panagopoulos I, Micci F (2018)
Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma
Oncotarget, 9 (27), 19203-19208
DOI 10.18632/oncotarget.24969, PubMed 29721194

Brunetti M, Holth A, Panagopoulos I, Staff AC, Micci F, Davidson B (2018)
Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma
Virchows Arch, 474 (2), 177-185
DOI 10.1007/s00428-018-2487-x, PubMed 30467600

Davidson B (2018)
Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies
Virchows Arch, 473 (4), 395-403
DOI 10.1007/s00428-018-2447-5, PubMed 30145616

Davidson B, Bjørnerem M, Holth A, Hellesylt E, Hetland Falkenthal TE, Flørenes VA (2018)
Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma
Gynecol Oncol, 150 (1), 136-142
DOI 10.1016/j.ygyno.2018.05.007, PubMed 29804637

Davidson B, Holth A, Wang Z, Hellsylt E, Tropé CG, Hetland Falkenthal TE, Holm R (2018)
Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma
APMIS, 126 (4), 309-313
DOI 10.1111/apm.12816, PubMed 29464778

Davidson B, Tötsch M, Wohlschlaeger J, Hager T, Pinamonti M (2018)
The diagnostic role of BAP1 in serous effusions
Hum Pathol, 79, 122-126
DOI 10.1016/j.humpath.2018.05.012, PubMed 29802871

Filippov-Levy N, Cohen-Schussheim H, Tropé CG, Hetland Falkenthal TE, Smith Y, Davidson B, Reich R (2018)
Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
Gynecol Oncol, 148 (3), 559-566
DOI 10.1016/j.ygyno.2018.01.004, PubMed 29310950

Flem Karlsen K, McFadden E, Flørenes VA, Davidson B (2018)
Soluble AXL is ubiquitously present in malignant serous effusions
Gynecol Oncol, 152 (2), 408-415
DOI 10.1016/j.ygyno.2018.11.012, PubMed 30448261

Lønning PE, Berge EO, Bjørnslett M, Minsaas L, Chrisanthar R, Høberg-Vetti H, Dulary C, Busato F, Bjørneklett S, Eriksen C, Kopperud R, Axcrona U, Davidson B, Bjørge L, Evans G, Howell A, Salvesen HB, Janszky I, Hveem K, Romundstad PR, Vatten LJ, Tost J, Dørum A, Knappskog S (2018)
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
Ann Intern Med, 168 (5), 326-334
DOI 10.7326/M17-0101, PubMed 29335712

Matias-Guiu X, Davidson B, Lax SF (2018)
Can the classification of low-grade endometrial stromal tumors still be improved?
Virchows Arch, 473 (6), 663-664
DOI 10.1007/s00428-018-2474-2, PubMed 30367239

Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B (2018)
Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma
Virchows Arch, 473 (4), 463-470
DOI 10.1007/s00428-018-2418-x, PubMed 30032361

Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K (2018)
Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only
Int J Gynecol Cancer, 28 (9), 1789-1795
DOI 10.1097/IGC.0000000000001356, PubMed 30365455

Publications 2017

Agostini A, Brunetti M, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
Oncotarget, 8 (13), 21554-21560
DOI 10.18632/oncotarget.15795, PubMed 28423547

Andersson Y, Haavardtun SI, Davidson B, Dørum A, Fleten KG, Fodstad Ø, Flatmark K (2017)
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer
Oncotarget, 8 (37), 61800-61809
DOI 10.18632/oncotarget.18694, PubMed 28977905

Brunetti M, Agostini A, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
Recurrent fusion transcripts in squamous cell carcinomas of the vulva
Oncotarget, 8 (10), 16843-16850
DOI 10.18632/oncotarget.15167, PubMed 28186972

Brunetti M, Panagopoulos I, Gorunova L, Davidson B, Heim S, Micci F (2017)
RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)
Genes Chromosomes Cancer, 57 (4), 176-181
DOI 10.1002/gcc.22518, PubMed 29218853

Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
Virchows Arch, 471 (3), 355-362
DOI 10.1007/s00428-017-2172-5, PubMed 28643014

Davidson B, Micci F (2017)
Molecular characteristics of uterine sarcomas
Expert Rev Mol Diagn, 17 (5), 515-522
DOI 10.1080/14737159.2017.1311790, PubMed 28335657

Davidson B, Pinamonti M, Cuevas D, Holth A, Zeppa P, Hager T, Wohlschlaeger J, Tötsch M (2017)
The diagnostic role of PTEN and ARID1A in serous effusions
Virchows Arch, 472 (3), 425-432
DOI 10.1007/s00428-017-2273-1, PubMed 29170871

Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ann Surg Oncol, 24 (7), 1916-1922
DOI 10.1245/s10434-017-5814-6, PubMed 28224367

Gutgold N, Davidson B, Catane LJ, Holth A, Hellesylt E, Tropé CG, Dørum A, Reich R (2017)
TGFβ splicing and canonical pathway activation in high-grade serous carcinoma
Virchows Arch, 470 (6), 665-678
DOI 10.1007/s00428-017-2127-x, PubMed 28432432

Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW (2017)
Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas
Am J Surg Pathol, 41 (9), 1231-1237
DOI 10.1097/PAS.0000000000000894, PubMed 28622181

Harel-Dassa K, Yedgar S, Tropé CG, Davidson B, Reich R (2017)
Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma
Hum Pathol, 62, 115-121
DOI 10.1016/j.humpath.2016.12.023, PubMed 28087476

Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA, Oliva E, Young RH, Hensley ML, Leitao MM, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S (2017)
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity
Mod Pathol, 31 (4), 674-684
DOI 10.1038/modpathol.2017.162, PubMed 29192652

Nastic D, Shanwell E, Wallin KL, Valla M, Måsbäck A, Mateoiu C, Lidang M, Liakka A, Lappi-Blanco E, Grove A, Davidson B, Carpen O, Bertelsen BI, Bak J, Abusland AB, Selling J, Carlson JW (2017)
A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis
Int J Gynecol Pathol, 36 (4), 339-347
DOI 10.1097/PGP.0000000000000334, PubMed 28244894

Phippen NT, Secord AA, Wolf S, Samsa G, Davidson B, Abernethy AP, Cella D, Havrilesky LJ, Burger RA, Monk BJ, Leath CA (2017)
Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study
Gynecol Oncol, 147 (1), 98-103
DOI 10.1016/j.ygyno.2017.07.121, PubMed 28743369

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, duBois A (2017)
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Int J Gynecol Cancer, 27 (7), 1534-1542
DOI 10.1097/IGC.0000000000001041, PubMed 30814245

Smebye ML, Agostini A, Johannessen B, Thorsen J, Davidson B, Tropé CG, Heim S, Skotheim RI, Micci F (2017)
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
BMC Cancer, 17 (1), 642
DOI 10.1186/s12885-017-3625-6, PubMed 28893231

Solheim O, Førsund M, Tropé CG, Kraggerud SM, Nesland JM, Davidson B (2017)
Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors
APMIS, 125 (9), 781-786
DOI 10.1111/apm.12715, PubMed 28585395

Valente R, Lykoudis P, Tamburrino D, Inama M, Passas I, Toumpanakis C, Luong TV, Davidson B, Imber C, Malagò M, Rahman SH, Shankar A, Sharma D, Caplin M, Fusai G (2017)
Major postoperative complications after pancreatic resection for P-NETS are not associated to earlier recurrence
Eur J Surg Oncol, 43 (11), 2119-2128
DOI 10.1016/j.ejso.2017.07.012, PubMed 28821361

Publications 2016

Agostini A, Brunetti M, Davidson B, Trope CG, Heim S, Panagopoulos I, Micci F (2016)
Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva
Oncotarget, 7 (51), 85058-85062
DOI 10.18632/oncotarget.13187, PubMed 27835588

Agostini A, Panagopoulos I, Davidson B, Trope CG, Heim S, Micci F (2016)
A novel truncated form of HMGA2 in tumors of the ovaries
Oncol Lett, 12 (2), 1559-1563
DOI 10.3892/ol.2016.4805, PubMed 27446471

Broner EC, Tropé CG, Reich R, Davidson B (2016)
TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma
Hum Pathol, 60, 180-187
DOI 10.1016/j.humpath.2016.10.017, PubMed 27825812

Davidson B (2016)
Recently identified drug resistance biomarkers in ovarian cancer
Expert Rev Mol Diagn, 16 (5), 569-78
DOI 10.1586/14737159.2016.1156532, PubMed 26895188

Davidson B (2016)
Malignant Nonhematological Effusion Characterization by Flow Cytometry
Acta Cytol, 60 (4), 365-371
DOI 10.1159/000447687, PubMed 27532128

Davidson B (2016)
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
Hum Pathol, 58, 123-127
DOI 10.1016/j.humpath.2016.08.005, PubMed 27589896

Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM (2016)
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
Am J Clin Pathol, 145 (4), 449-58
DOI 10.1093/ajcp/aqw030, PubMed 27149024

Davidson B, Valborg Reinertsen K, Trinh D, Reed W, Bøhler PJ (2016)
BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma
Hum Pathol, 54, 64-73
DOI 10.1016/j.humpath.2016.02.023, PubMed 27038683

Horwitz V, Davidson B, Stern D, Tropé CG, Tavor Re'em T, Reich R (2016)
Ezrin Is Associated with Disease Progression in Ovarian Carcinoma
PLoS One, 11 (9), e0162502
DOI 10.1371/journal.pone.0162502, PubMed 27622508

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL (2016)
Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
Cancer Res, 76 (21), 6351-6361
DOI 10.1158/0008-5472.CAN-16-0980, PubMed 27590741

Lee JC, Lu TP, Changou CA, Liang CW, Huang HN, Lauria A, Huang HY, Lin CY, Chiang YC, Davidson B, Lin MC, Kuo KT (2016)
Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup
Mod Pathol, 29 (9), 1070-82
DOI 10.1038/modpathol.2016.99, PubMed 27255164

Lehtinen L, Vesterkvist P, Roering P, Korpela T, Hattara L, Kaipio K, Mpindi JP, Hynninen J, Auranen A, Davidson B, Haglund C, Iljin K, Grenman S, Siitari H, Carpen O (2016)
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker
PLoS One, 11 (3), e0151590
DOI 10.1371/journal.pone.0151590, PubMed 26981633

Micci F, Gorunova L, Agostini A, Johannessen LE, Brunetti M, Davidson B, Heim S, Panagopoulos I (2016)
Cytogenetic and molecular profile of endometrial stromal sarcoma
Genes Chromosomes Cancer, 55 (11), 834-46
DOI 10.1002/gcc.22380, PubMed 27219024

Michael CW, Davidson B (2016)
Pre-analytical issues in effusion cytology
Pleura Peritoneum, 1 (1), 45-56
DOI 10.1515/pp-2016-0001, PubMed 30911607

Nymoen DA, Slipicevic A, Holth A, Emilsen E, Hetland Falkenthal TE, Tropé CG, Reich R, Flørenes VA, Davidson B (2016)
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Hum Pathol, 54, 74-81
DOI 10.1016/j.humpath.2016.03.010, PubMed 27063471

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, du Bois A (2016)
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Int J Gynecol Cancer, 26 (7), 1354-63
DOI 10.1097/IGC.0000000000000767, PubMed 27648648

Ravid Y, Formanski M, Smith Y, Reich R, Davidson B (2016)
Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures
Gynecol Oncol, 140 (3), 512-7
DOI 10.1016/j.ygyno.2016.01.001, PubMed 26768834

Smebye ML, Haugom L, Davidson B, Trope CG, Heim S, Skotheim RI, Micci F (2016)
Bilateral ovarian carcinomas differ in the expression of metastasis-related genes
Oncol Lett, 13 (1), 184-190
DOI 10.3892/ol.2016.5384, PubMed 28123539

Smogeli E, Davidson B, Cvancarova M, Holth A, Katz B, Risberg B, Kristensen G, Lindemann K (2016)
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
BMC Cancer, 16, 596
DOI 10.1186/s12885-016-2631-4, PubMed 27488577

Tambe M, Pruikkonen S, Mäki-Jouppila J, Chen P, Elgaaen BV, Straume AH, Huhtinen K, Cárpen O, Lønning PE, Davidson B, Hautaniemi S, Kallio MJ (2016)
Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel
Oncotarget, 7 (11), 12267-85
DOI 10.18632/oncotarget.7860, PubMed 26943585

van der Putten LJ, van de Vijver K, Bartosch C, Davidson B, Gatius S, Matias-Guiu X, McCluggage WG, Toledo G, van der Wurff AA, Pijnenborg JM, Massuger LF, Bulten J (2016)
Reproducibility of measurement of myometrial invasion in endometrial carcinoma
Virchows Arch, 470 (1), 63-68
DOI 10.1007/s00428-016-2035-5, PubMed 27787595

Publications 2015

Agostini A, Panagopoulos I, Andersen HK, Johannesen LE, Davidson B, Tropé CG, Heim S, Micci F (2015)
HMGA2 expression pattern and TERT mutations in tumors of the vulva
Oncol Rep, 33 (6), 2675-80
DOI 10.3892/or.2015.3882, PubMed 25823555

Bartlett TE, Jones A, Goode EL, Fridley BL, Cunningham JM, Berns EM, Wik E, Salvesen HB, Davidson B, Trope CG, Lambrechts S, Vergote I, Widschwendter M (2015)
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers
PLoS One, 10 (12), e0143178
DOI 10.1371/journal.pone.0143178, PubMed 26629914

Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Papastergiou V, Thalassinos E, Mantzoukis K, Rodriguez-Peralvarez M, O'Brien J, Noel-Storr A, Papatheodoridis GV, Davidson B, Burroughs AK (2015)
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation
J Viral Hepat, 23 (2), 139-49
DOI 10.1111/jvh.12469, PubMed 26444996

Davidson B (2015)
Prognostic factors in malignant pleural mesothelioma
Hum Pathol, 46 (6), 789-804
DOI 10.1016/j.humpath.2015.02.006, PubMed 25824607

Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Tropé CG, Reich R (2015)
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival
Hum Pathol, 48, 95-101
DOI 10.1016/j.humpath.2015.09.027, PubMed 26640230

Davidson B, Stavnes HT, Hellesylt E, Hager T, Zeppa P, Pinamonti M, Wohlschlaeger J (2015)
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions
Hum Pathol, 47 (1), 104-8
DOI 10.1016/j.humpath.2015.08.020, PubMed 26520416

Hjerpe A, Ascoli V, Bedrossian C, Boon M, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Cytojournal, 12, 26
DOI 10.4103/1742-6413.170726, PubMed 26681974

Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication
Cytopathology, 26 (3), 142-56
DOI 10.1111/cyt.12250, PubMed 26052757

Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P, International Mesothelioma Interest Group, International Academy of Cytology (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Diagn Cytopathol, 43 (7), 563-76
DOI 10.1002/dc.23271, PubMed 26100969

Hjerpe A, Ascoli V, Bedrossian CWM, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Acta Cytol, 59 (1), 2-16
DOI 10.1159/000377697, PubMed 25824655

Howell VM, Davidson B (2015)
Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
Front Oncol, 5, 205
DOI 10.3389/fonc.2015.00205, PubMed 26442217

Jakobsson ME, Moen A, Davidson B, Falnes PØ (2015)
Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma
PLoS One, 10 (10), e0140168
DOI 10.1371/journal.pone.0140168, PubMed 26448330

Katz B, Tropé CG, Reich R, Davidson B (2015)
MicroRNAs in Ovarian Cancer
Hum Pathol, 46 (9), 1245-56
DOI 10.1016/j.humpath.2015.06.013, PubMed 26216350

Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
Mol Oncol, 9 (6), 1129-39
DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404

Malik H, Khan AZ, Berry DP, Cameron IC, Pope I, Sherlock D, Helmy S, Byrne B, Thompson M, Pulfer A, Davidson B (2015)
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study
Eur J Surg Oncol, 41 (4), 499-505
DOI 10.1016/j.ejso.2015.01.032, PubMed 25703078

McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-Guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L, International Collaboration on Cancer Reporting (2015)
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Mod Pathol, 28 (8), 1101-22
DOI 10.1038/modpathol.2015.77, PubMed 26089092

Nymoen DA, Hetland Falkenthal TE, Holth A, Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC, Davidson B (2015)
Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma
Gynecol Oncol, 139 (1), 30-9
DOI 10.1016/j.ygyno.2015.07.107, PubMed 26232338

Nymoen DA, Holth A, Hetland Falkenthal TE, Tropé CG, Davidson B (2015)
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
Mol Cancer, 14, 44
DOI 10.1186/s12943-015-0317-1, PubMed 25889687

Oliver D, Ledger J, Davidson B, Thompson N, Northern Nutrition Network (2015)
Developing regional nutrition team training across the North-East of England: reporting on the first nutrition team course run by the Northern Nutrition Network
Clin Nutr ESPEN, 10 (5), e194
DOI 10.1016/j.clnesp.2015.03.041, PubMed 28531510

Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, Chindera K, Evans I, Dubeau L, Orjalo A, Horlings HM, Niederreiter L, Kaser A, Yang W, Goode EL, Fridley BL, Jenner RG, Berns EM, Wik E, Salvesen HB, Wisman GB, van der Zee AG, Davidson B, Trope CG, Lambrechts S et al. (2015)
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Genome Med, 7, 108
DOI 10.1186/s13073-015-0233-4, PubMed 26497652

Yu Y, Gaillard S, Phillip JM, Huang TC, Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A, Davidson B, Wang TL, Shih IeM (2015)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
Cancer Cell, 28 (1), 82-96
DOI 10.1016/j.ccell.2015.05.009, PubMed 26096845

Publications 2014

Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP (2014)
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Hum Pathol, 46 (1), 1-8
DOI 10.1016/j.humpath.2014.10.004, PubMed 25455994

Davidson B, Nymoen DA, Elgaaen BV, Staff AC, Tropé CG, Kærn J, Reich R, Falkenthal TE (2014)
BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma
Virchows Arch, 464 (6), 701-7
DOI 10.1007/s00428-014-1577-7, PubMed 24756216

Davidson B, Rosenfeld YB, Holth A, Hellesylt E, Tropé CG, Reich R, Yisraeli JK (2014)
VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
Hum Pathol, 45 (7), 1520-8
DOI 10.1016/j.humpath.2014.03.005, PubMed 24814803

Davidson B, Tropé CG (2014)
Ovarian cancer: diagnostic, biological and prognostic aspects
Womens Health (Lond), 10 (5), 519-33
DOI 10.2217/whe.14.37, PubMed 25335543

Davidson B, Tropé CG, Reich R (2014)
The clinical and diagnostic role of microRNAs in ovarian carcinoma
Gynecol Oncol, 133 (3), 640-6
DOI 10.1016/j.ygyno.2014.03.575, PubMed 24713546

Davidson B, Trope CG, Reich R (2014)
The role of the tumor stroma in ovarian cancer
Front Oncol, 4, 104
DOI 10.3389/fonc.2014.00104, PubMed 24860785

Laporte M, Keller HH, Payette H, Allard JP, Duerksen DR, Bernier P, Jeejeebhoy K, Gramlich L, Davidson B, Vesnaver E, Teterina A (2014)
Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting
Eur J Clin Nutr, 69 (5), 558-64
DOI 10.1038/ejcn.2014.270, PubMed 25514899

Maimon A, Mogilevsky M, Shilo A, Golan-Gerstl R, Obiedat A, Ben-Hur V, Lebenthal-Loinger I, Stein I, Reich R, Beenstock J, Zehorai E, Andersen CL, Thorsen K, Ørntoft TF, Davis RJ, Davidson B, Mu D, Karni R (2014)
Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation
Cell Rep, 7 (2), 501-513
DOI 10.1016/j.celrep.2014.03.041, PubMed 24726367

Matias-Guiu X, Davidson B (2014)
Prognostic biomarkers in endometrial and ovarian carcinoma
Virchows Arch, 464 (3), 315-31
DOI 10.1007/s00428-013-1509-y, PubMed 24504546

Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, Panagopoulos I (2014)
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma
Cancer Lett, 347 (1), 75-8
DOI 10.1016/j.canlet.2014.01.030, PubMed 24530230

Micci F, Haugom L, Abeler VM, Davidson B, Tropé CG, Heim S (2014)
Genomic profile of ovarian carcinomas
BMC Cancer, 14, 315
DOI 10.1186/1471-2407-14-315, PubMed 24886194

Micci F, Panagopoulos I, Thorsen J, Davidson B, Tropé CG, Heim S (2014)
Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas
PLoS Biol, 12 (2), e1001784
DOI 10.1371/journal.pbio.1001784, PubMed 24504521

Panagopoulos I, Gorunova L, Davidson B, Heim S (2014)
Novel TNS3-MAP3K3 and ZFPM2-ELF5 fusion genes identified by RNA sequencing in multicystic mesothelioma with t(7;17)(p12;q23) and t(8;11)(q23;p13)
Cancer Lett, 357 (2), 502-9
DOI 10.1016/j.canlet.2014.12.002, PubMed 25484136

Slipicevic A, Holth A, Hellesylt E, Tropé CG, Davidson B, Flørenes VA (2014)
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
Gynecol Oncol, 135 (1), 118-24
DOI 10.1016/j.ygyno.2014.07.102, PubMed 25093290

Smebye ML, Sveen A, Haugom L, Davidson B, Tropé CG, Lothe RA, Heim S, Skotheim RI, Micci F (2014)
Chromosome 19 rearrangements in ovarian carcinomas: zinc finger genes are particularly targeted
Genes Chromosomes Cancer, 53 (7), 558-67
DOI 10.1002/gcc.22166, PubMed 24634323

Tuft Stavnes H, Nymoen DA, Hetland Falkenthal TE, Kærn J, Tropé CG, Davidson B (2014)
APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival
Am J Clin Pathol, 142 (1), 51-7
DOI 10.1309/AJCPD8NBSHXRXQL7, PubMed 24926085

Vaksman O, Tropé C, Davidson B, Reich R (2014)
Exosome-derived miRNAs and ovarian carcinoma progression
Carcinogenesis, 35 (9), 2113-20
DOI 10.1093/carcin/bgu130, PubMed 24925027

Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B (2014)
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
BMC Cancer, 14, 80
DOI 10.1186/1471-2407-14-80, PubMed 24512620

Publications 2013

Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013)
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort
Mol Cell Proteomics, 12 (6), 1621-31
DOI 10.1074/mcp.M112.026427, PubMed 23449826

Davidson B (2013)
Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions
Cancer Cytopathol, 122 (2), 153-8
DOI 10.1002/cncy.21353, PubMed 24115587

Davidson B, Abeler VM, Førsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL (2013)
Gene expression signatures of primary and metastatic uterine leiomyosarcoma
Hum Pathol, 45 (4), 691-700
DOI 10.1016/j.humpath.2013.11.003, PubMed 24485798

Davidson B, Smith Y, Nesland JM, Kærn J, Reich R, Tropè CG (2013)
Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion
Hum Pathol, 44 (11), 2449-60
DOI 10.1016/j.humpath.2013.06.003, PubMed 24011953

Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH (2013)
Histotype-genotype correlation in 36 high-grade endometrial carcinomas
Am J Surg Pathol, 37 (9), 1421-32
DOI 10.1097/PAS.0b013e31828c63ed, PubMed 24076778

Keller HH, Vesnaver E, Davidson B, Allard J, Laporte M, Bernier P, Payette H, Jeejeebhoy K, Duerksen D, Gramlich L (2013)
Providing quality nutrition care in acute care hospitals: perspectives of nutrition care personnel
J Hum Nutr Diet, 27 (2), 192-202
DOI 10.1111/jhn.12170, PubMed 24147893

Micci F, Panagopoulos I, Haugom L, Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Tropé CG, Danielsen HE, Heim S (2013)
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva
Genes Chromosomes Cancer, 52 (6), 551-63
DOI 10.1002/gcc.22053, PubMed 23404381

Panagopoulos I, Thorsen J, Gorunova L, Haugom L, Bjerkehagen B, Davidson B, Heim S, Micci F (2013)
Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation
Genes Chromosomes Cancer, 52 (7), 610-8
DOI 10.1002/gcc.22057, PubMed 23580382

Panagopoulos I, Thorsen J, Gorunova L, Micci F, Haugom L, Davidson B, Heim S (2013)
RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)
Genes Chromosomes Cancer, 52 (8), 733-40
DOI 10.1002/gcc.22068, PubMed 23630070

Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B (2013)
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
Gynecol Oncol, 129 (2), 358-63
DOI 10.1016/j.ygyno.2013.02.021, PubMed 23438671

Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S (2013)
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
EMBO Mol Med, 5 (7), 1051-66
DOI 10.1002/emmm.201201823, PubMed 23666744

Vaksman O, Davidson B, Tropé C, Reich R (2013)
Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
Hum Pathol, 44 (12), 2677-83
DOI 10.1016/j.humpath.2013.07.009, PubMed 24060004

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF (2013)
Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma
Hum Pathol, 44 (9), 1859-66
DOI 10.1016/j.humpath.2013.02.009, PubMed 23656974

Publications 2012

Ben-Hur V, Denichenko P, Siegfried Z, Maimon A, Krainer A, Davidson B, Karni R (2012)
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1
Cell Rep, 3 (1), 103-15
DOI 10.1016/j.celrep.2012.11.020, PubMed 23273915

Brenne K, Nymoen DA, Reich R, Davidson B (2012)
PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma
Am J Clin Pathol, 137 (2), 240-7
DOI 10.1309/AJCPGA95KVSAUDMF, PubMed 22261449

Brusegard K, Stavnes HT, Nymoen DA, Flatmark K, Trope CG, Davidson B (2012)
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
Virchows Arch, 460 (2), 193-202
DOI 10.1007/s00428-011-1191-x, PubMed 22249560

Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL (2012)
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Gynecol Oncol, 128 (2), 349-55
DOI 10.1016/j.ygyno.2012.11.021, PubMed 23178314

Davidson B, Dong HP, Berner A, Risberg B (2012)
The diagnostic and research applications of flow cytometry in cytopathology
Diagn Cytopathol, 40 (6), 525-35
DOI 10.1002/dc.22809, PubMed 22619127

Davidson B, Holth A, Nguyen MT, Tropé CG, Wu C (2012)
Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases
Gynecol Oncol, 128 (2), 364-70
DOI 10.1016/j.ygyno.2012.10.015, PubMed 23099104

Davidson B, Tropé CG, Reich R (2012)
Epithelial-mesenchymal transition in ovarian carcinoma
Front Oncol, 2, 33
DOI 10.3389/fonc.2012.00033, PubMed 22655269

Elstrand MB, Sandstad B, Oksefjell H, Davidson B, Tropé CG (2012)
Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
Acta Obstet Gynecol Scand, 91 (3), 308-17
DOI 10.1111/j.1600-0412.2011.01316.x, PubMed 22050605

Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM (2012)
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
Clin Cancer Res, 18 (11), 3197-206
DOI 10.1158/1078-0432.CCR-12-0056, PubMed 22492981

Hetland TE, Holth A, Kærn J, Flørenes VA, Tropé CG, Davidson B (2012)
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
Virchows Arch, 460 (5), 505-13
DOI 10.1007/s00428-012-1228-9, PubMed 22476403

Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA (2012)
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index
Cancer Chemother Pharmacol, 69 (5), 1307-14
DOI 10.1007/s00280-012-1835-9, PubMed 22302409

Hetland TE, Nymoen DA, Emilsen E, Kærn J, Tropé CG, Flørenes VA, Davidson B (2012)
MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival
Gynecol Oncol, 126 (3), 460-5
DOI 10.1016/j.ygyno.2012.05.029, PubMed 22652154

Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, Tropé CG, Davidson B (2012)
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Hum Pathol, 44 (5), 777-85
DOI 10.1016/j.humpath.2012.08.002, PubMed 23114921

Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM (2012)
IKK-ε coordinates invasion and metastasis of ovarian cancer
Cancer Res, 72 (21), 5494-504
DOI 10.1158/0008-5472.CAN-11-3993, PubMed 22942254

Konstantinovsky S, Davidson B, Reich R (2012)
Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids
Clin Exp Metastasis, 29 (6), 527-40
DOI 10.1007/s10585-012-9468-2, PubMed 22476538

Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S (2012)
Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma
PLoS One, 7 (6), e39354
DOI 10.1371/journal.pone.0039354, PubMed 22761769

Pradhan M, Davidson B, Abeler VM, Danielsen HE, Tropé CG, Kristensen GB, Risberg BÅ (2012)
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Virchows Arch, 461 (3), 291-8
DOI 10.1007/s00428-012-1275-2, PubMed 22824999

Sebban S, Golan-Gerstl R, Karni R, Vaksman O, Davidson B, Reich R (2012)
Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer
Clin Exp Metastasis, 30 (1), 103-17
DOI 10.1007/s10585-012-9514-0, PubMed 22806361

Stavnes HT, Nymoen DA, Langerød A, Holth A, Børresen Dale AL, Davidson B (2012)
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
Virchows Arch, 462 (2), 163-73
DOI 10.1007/s00428-012-1347-3, PubMed 23242172

Tropé CG, Elstrand MB, Sandstad B, Davidson B, Oksefjell H (2012)
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
Eur J Cancer, 48 (14), 2146-54
DOI 10.1016/j.ejca.2012.01.031, PubMed 22382201

Tropé CG, Kaern J, Davidson B (2012)
Borderline ovarian tumours
Best Pract Res Clin Obstet Gynaecol, 26 (3), 325-36
DOI 10.1016/j.bpobgyn.2011.12.006, PubMed 22321906

Vaksman O, Hetland TE, Trope' CG, Reich R, Davidson B (2012)
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma
Hum Pathol, 43 (11), 2062-9
DOI 10.1016/j.humpath.2012.02.016, PubMed 22647351

Weiss I, Trope CG, Reich R, Davidson B (2012)
Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure
Int J Mol Sci, 13 (10), 12925-38
DOI 10.3390/ijms131012925, PubMed 23202930

Publications 2011

Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA (2011)
Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF
Gene Ther, 19 (5), 483-93
DOI 10.1038/gt.2011.114, PubMed 21918547

Bock AJ, Dong HP, Tropé CG, Staff AC, Risberg B, Davidson B (2011)
Nucleoside transporters are widely expressed in ovarian carcinoma effusions
Cancer Chemother Pharmacol, 69 (2), 467-75
DOI 10.1007/s00280-011-1716-7, PubMed 21822668

Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B (2011)
SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions
Hum Pathol, 43 (5), 669-74
DOI 10.1016/j.humpath.2011.06.003, PubMed 21855113

Bock AJ, Tuft Stavnes H, Kærn J, Berner A, Staff AC, Davidson B (2011)
Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
Tumour Biol, 32 (3), 589-96
DOI 10.1007/s13277-011-0157-6, PubMed 21350924

Brenne K, Nymoen DA, Hetland TE, Trope' CG, Davidson B (2011)
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
Hum Pathol, 43 (4), 496-505
DOI 10.1016/j.humpath.2011.05.023, PubMed 21855111

Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM (2011)
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome
Hum Pathol, 42 (7), 991-7
DOI 10.1016/j.humpath.2010.10.013, PubMed 21315424

Davidson B, Stavnes HT, Holth A, Chen X, Yang Y, Shih IeM, Wang TL (2011)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
J Cell Mol Med, 15 (3), 535-44
DOI 10.1111/j.1582-4934.2010.01023.x, PubMed 20132413

Davidson B, Stavnes HT, Risberg B, Nesland JM, Wohlschlaeger J, Yang Y, Shih IeM, Wang TL (2011)
Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions
Hum Pathol, 43 (5), 684-94
DOI 10.1016/j.humpath.2011.06.015, PubMed 21937081

Dong HP, Ree Rosnes AK, Bock AJ, Holth A, Flørenes VA, Trope' CG, Risberg B, Davidson B (2011)
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions
Cytopathology, 22 (6), 373-82
DOI 10.1111/j.1365-2303.2011.00929.x, PubMed 22032542

Elstrand MB, Stavnes HT, Tropé CG, Davidson B (2011)
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
Hum Pathol, 43 (4), 529-35
DOI 10.1016/j.humpath.2011.05.022, PubMed 21864883

Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Proc Natl Acad Sci U S A, 108 (46), 18708-13
DOI 10.1073/pnas.1111840108, PubMed 22068913

Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, Gottesman MM (2011)
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions
Mol Pharm, 8 (6), 2080-8
DOI 10.1021/mp200240a, PubMed 21761824

Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J (2011)
Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
Hum Pathol, 42 (7), 1019-26
DOI 10.1016/j.humpath.2010.10.025, PubMed 21315408

Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011)
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells
Gynecol Oncol, 122 (3), 656-62
DOI 10.1016/j.ygyno.2011.04.052, PubMed 21676452

Kim G, Davidson B, Henning R, Wang J, Yu M, Annunziata C, Hetland T, Kohn EC (2011)
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome
Cancer, 118 (6), 1543-53
DOI 10.1002/cncr.26449, PubMed 22009736

Reich R, Hadar S, Davidson B (2011)
Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma
Int J Mol Sci, 12 (2), 1133-45
DOI 10.3390/ijms12021133, PubMed 21541048

Safdar N, McKinley LM, Davidson B, Broome C, Schenk J (2011)
Recommendations to replace peripheral venous catheters every 72-96 hours: is a single reference enough?
J Hosp Infect, 79 (2), 172-3
DOI 10.1016/j.jhin.2011.06.005, PubMed 21802173

Schmitt F, Cochand-Priollet B, Toetsch M, Davidson B, Bondi A, Vielh P (2011)
Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry
Cytopathology, 22 (4), 238-42
DOI 10.1111/j.1365-2303.2011.00885.x, PubMed 21771093

Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R (2011)
miRNA profiling along tumour progression in ovarian carcinoma
J Cell Mol Med, 15 (7), 1593-602
DOI 10.1111/j.1582-4934.2010.01148.x, PubMed 20716115

Venkatesh B, Davidson B, Robinson K, Pascoe R, Appleton C, Jones M (2011)
Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill?
Intensive Care Med, 38 (1), 177-9
DOI 10.1007/s00134-011-2415-x, PubMed 22113816

Yuan Y, Dong HP, Nymoen DA, Nesland JM, Wu C, Davidson B (2011)
PINCH-2 expression in cancers involving serosal effusions using quantitative PCR
Cytopathology, 22 (1), 22-9
DOI 10.1111/j.1365-2303.2010.00757.x, PubMed 20500520

Publications 2010

Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010)
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
Cancer, 116 (13), 3276-84
DOI 10.1002/cncr.25190, PubMed 20564628

Bock AJ, Stavnes HT, Kempf T, Tropè CG, Berner A, Davidson B, Staff AC (2010)
Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions
Int J Gynecol Cancer, 20 (9), 1448-55
DOI 10.1111/IGC.0b013e3181f7d6be, PubMed 21336029

Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, Tropé CG, Davidson B (2010)
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
Hum Pathol, 41 (6), 794-804
DOI 10.1016/j.humpath.2009.09.017, PubMed 20153512

Davidson B (2010)
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
Cytopathology, 22 (1), 5-21
DOI 10.1111/j.1365-2303.2010.00829.x, PubMed 21114695

Davidson B, Reich R, Trope CG, Wang TL, Shih IeM (2010)
New determinates of disease progression and outcome in metastatic ovarian carcinoma
Histol Histopathol, 25 (12), 1591-609
DOI 10.14670/HH-25.1591, PubMed 20886439

Davidson B, Stavnes HT, Førsund M, Berner A, Staff AC (2010)
CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival
Breast, 19 (6), 493-8
DOI 10.1016/j.breast.2010.05.013, PubMed 21078485

Dong HP, Holth A, Ruud MG, Emilsen E, Risberg B, Davidson B (2010)
Measurement of apoptosis in cytological specimens by flow cytometry: comparison of Annexin V, caspase cleavage and dUTP incorporation assays
Cytopathology, 22 (6), 365-72
DOI 10.1111/j.1365-2303.2010.00811.x, PubMed 21054589

Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R (2010)
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions
Clin Exp Metastasis, 27 (3), 161-72
DOI 10.1007/s10585-010-9315-2, PubMed 20213325

Flatmark K, Davidson B, Kristian A, Stavnes HT, Førsund M, Reed W (2010)
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
Hum Pathol, 41 (8), 1109-19
DOI 10.1016/j.humpath.2009.12.013, PubMed 20338618

Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010)
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer
Cancer Res, 70 (10), 4005-14
DOI 10.1158/0008-5472.CAN-09-3912, PubMed 20424119

Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM, Davidson B, Wang TL, Shih IeM (2010)
Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma
PLoS One, 5 (6), e11198
DOI 10.1371/journal.pone.0011198, PubMed 20585448

Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S (2010)
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
DOI 10.1186/1479-5876-8-21, PubMed 20184781

Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA (2010)
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
Int J Cancer, 126 (2), 350-61
DOI 10.1002/ijc.24727, PubMed 19588500

Park JT, Chen X, Tropè CG, Davidson B, Shih IeM, Wang TL (2010)
Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin
Am J Pathol, 177 (3), 1087-94
DOI 10.2353/ajpath.2010.100316, PubMed 20671266

Pradhan M, Abeler VM, Davidson B, Kildal W, Nybøen A, Tropé CG, Risberg B, Danielsen HE (2010)
DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
Int J Gynecol Pathol, 29 (6), 572-8
DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853

Shih IeM, Chen L, Wang CC, Gu J, Davidson B, Cope L, Kurman RJ, Xuan J, Wang TL (2010)
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis
Am J Obstet Gynecol, 203 (6), 584.e1-22
DOI 10.1016/j.ajog.2010.08.003, PubMed 20965493

Staff AC, Bock AJ, Becker C, Kempf T, Wollert KC, Davidson B (2010)
Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
Gynecol Oncol, 118 (3), 237-43
DOI 10.1016/j.ygyno.2010.05.032, PubMed 20576287

Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM (2010)
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
J Oncol, 2010, 285191
DOI 10.1155/2010/285191, PubMed 20508725

Wang TL, Davidson B, Buckhaults PJ, Huang CS, Poul G (2010)
Molecular genetic markers in female reproductive cancers
J Oncol, 2010, 307460
DOI 10.1155/2010/307460, PubMed 21541207

Yu GQ, Feng YJ, Miller DJ, Xuan JH, Hoffman EP, Clarke R, Davidson B, Shih IM, Wang Y (2010)
Matched Gene Selection and Committee Classifier for Molecular Classification of Heterogeneous Diseases
J. Mach. Learn. Res., 11, 2141-2167

Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B (2010)
Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors
Diagn Cytopathol, 39 (8), 562-6
DOI 10.1002/dc.21424, PubMed 20730893

Publications 2009

Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R (2009)
Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival
Hum Pathol, 40 (5), 705-13
DOI 10.1016/j.humpath.2008.09.019, PubMed 19157507

Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B (2009)
Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters
Am J Clin Pathol, 132 (5), 756-62
DOI 10.1309/AJCPAVFA8J3KHPRS, PubMed 19846818

Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B (2009)
Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma
Int J Gynecol Pathol, 28 (3), 211-21
DOI 10.1097/PGP.0b013e31818b0f5e, PubMed 19620938

Kleinberg L, Davidson B (2009)
Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review
Diagn Cytopathol, 37 (8), 613-24
DOI 10.1002/dc.21095, PubMed 19418469

Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B (2009)
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
Hum Pathol, 40 (6), 795-806
DOI 10.1016/j.humpath.2008.10.019, PubMed 19157506

Konstantinovsky S, Smith Y, Zilber S, Tuft Stavnes H, Becker AM, Nesland JM, Reich R, Davidson B (2009)
Breast carcinoma cells in primary tumors and effusions have different gene array profiles
J Oncol, 2010, 969084
DOI 10.1155/2010/969084, PubMed 19680458

Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B (2009)
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
Tumour Biol, 30 (1), 15-25
DOI 10.1159/000199447, PubMed 19194111

Pradhan M, Davidson B, Tropé CG, Danielsen HE, Abeler VM, Risberg B (2009)
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
Virchows Arch, 454 (6), 677-83
DOI 10.1007/s00428-009-0778-y, PubMed 19421773

Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009)
Large scale genomic instability as an additive prognostic marker in early prostate cancer
Cell Oncol, 31 (4), 251-9
DOI 10.3233/CLO-2009-0463, PubMed 19633362

Shih IeM, Davidson B (2009)
Pathogenesis of ovarian cancer: clues from selected overexpressed genes
Future Oncol, 5 (10), 1641-57
DOI 10.2217/fon.09.126, PubMed 20001801

Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B (2009)
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions
Hum Pathol, 40 (4), 527-37
DOI 10.1016/j.humpath.2008.10.003, PubMed 19121847

Tropé C, Davidson B, Paulsen T, Abeler VM, Kaern J (2009)
Diagnosis and treatment of borderline ovarian neoplasms "the state of the art"
Eur J Gynaecol Oncol, 30 (5), 471-82
PubMed 19899396

Virador VM, Davidson B, Czechowicz J, Mai A, Kassis J, Kohn EC (2009)
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome
PLoS One, 4 (4), e5136
DOI 10.1371/journal.pone.0005136, PubMed 19352495

Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B (2009)
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Hum Pathol, 40 (10), 1453-60
DOI 10.1016/j.humpath.2009.02.013, PubMed 19454358

Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjørang O, Wu C, Nesland JM, Davidson B (2009)
Tenascin-X is a novel diagnostic marker of malignant mesothelioma
Am J Surg Pathol, 33 (11), 1673-82
DOI 10.1097/PAS.0b013e3181b6bde3, PubMed 19738457

Publications 2008

Choi JH, Park JT, Davidson B, Morin PJ, Shih IeM, Wang TL (2008)
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion
Cancer Res, 68 (14), 5716-23
DOI 10.1158/0008-5472.CAN-08-0001, PubMed 18632624

Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W, Becker KG, Morin PJ (2008)
MicroRNA expression and identification of putative miRNA targets in ovarian cancer
PLoS One, 3 (6), e2436
DOI 10.1371/journal.pone.0002436, PubMed 18560586

Davidson B (2008)
New diagnostic and molecular characteristics of malignant mesothelioma
Ultrastruct Pathol, 32 (6), 227-40
DOI 10.1080/01913120802454298, PubMed 19117264

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2008)
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions
Breast J, 14 (5), 476-82
DOI 10.1111/j.1524-4741.2008.00625.x, PubMed 18657145

Davidson B, Shih IeM, Wang TL (2008)
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma
Hum Pathol, 39 (11), 1630-6
DOI 10.1016/j.humpath.2008.03.009, PubMed 18656238

Davidson B, Wang TL, Shih IeM, Berner A (2008)
Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions
Hum Pathol, 39 (4), 616-22
DOI 10.1016/j.humpath.2007.09.008, PubMed 18289639

Dong HP, Kleinberg L, Davidson B, Risberg B (2008)
Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry
Nat Protoc, 3 (6), 955-64
DOI 10.1038/nprot.2008.77, PubMed 18546596

Dong HP, Kleinberg L, Silins I, Flørenes VA, Tropé CG, Risberg B, Nesland JM, Davidson B (2008)
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
Cancer, 112 (1), 84-93
DOI 10.1002/cncr.23140, PubMed 17985388

Kleinberg L, Holth A, Trope CG, Reich R, Davidson B (2008)
Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
Hum Pathol, 39 (5), 747-57
DOI 10.1016/j.humpath.2007.10.002, PubMed 18439941

Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B (2008)
Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors
Diagn Cytopathol, 36 (9), 637-44
DOI 10.1002/dc.20879, PubMed 18677760

Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R (2008)
Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells
Cancer Res, 68 (22), 9265-73
DOI 10.1158/0008-5472.CAN-08-2093, PubMed 19010899

Sebban S, Davidson B, Reich R (2008)
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities
Virchows Arch, 454 (1), 71-9
DOI 10.1007/s00428-008-0694-6, PubMed 19015874

Slipicevic A, Jørgensen K, Skrede M, Rosnes AK, Trøen G, Davidson B, Flørenes VA (2008)
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
BMC Cancer, 8, 276
DOI 10.1186/1471-2407-8-276, PubMed 18826602

Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC (2008)
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
Am J Obstet Gynecol, 198 (4), 418.e1-7
DOI 10.1016/j.ajog.2007.10.792, PubMed 18241816

Ødegaard E, Davidson B, Engh V, Onsrud M, Staff AC (2008)
Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary
Am J Obstet Gynecol, 199 (5), 533.e1-8
DOI 10.1016/j.ajog.2008.04.004, PubMed 18533117

Publications 2007

Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC (2007)
BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer
Clin Cancer Res, 13 (22 Pt 1), 6585-92
DOI 10.1158/1078-0432.CCR-07-0327, PubMed 18006758

Davidson B (2007)
Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma
Curr Cancer Drug Targets, 7 (1), 109-20
DOI 10.2174/156800907780006904, PubMed 17305482

Davidson B (2007)
Biological characteristics of cancers involving the serosal cavities
Crit Rev Oncog, 13 (3), 189-227
DOI 10.1615/critrevoncog.v13.i3.10, PubMed 18298385

Davidson B (2007)
Expression of cancer-associated molecules in malignant mesothelioma
Biomark Insights, 2, 173-84
PubMed 19662202

Davidson B, Baekelandt M, Shih IeM (2007)
MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells
Diagn Cytopathol, 35 (12), 756-60
DOI 10.1002/dc.20771, PubMed 18008338

Davidson B, Berner A, Trope' CG, Wang TL, Shih IM (2007)
Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions
Hum Pathol, 38 (7), 1030-1036
DOI 10.1016/j.humpath.2006.12.009, PubMed 17391728

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
Am J Clin Pathol, 127 (5), 752-9
DOI 10.1309/LN2075V7C8K31CH8, PubMed 17439834

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications
Diagn Cytopathol, 35 (9), 568-78
DOI 10.1002/dc.20707, PubMed 17703449

Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, Risberg B, Flørenes VA, Kopolovic J, Reich R (2007)
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Hum Pathol, 39 (1), 87-95
DOI 10.1016/j.humpath.2007.05.014, PubMed 17949781

Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA (2007)
Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma
Cancer, 110 (6), 1264-71
DOI 10.1002/cncr.22918, PubMed 17647260

Davidson B, Xi Z, Saatcioglu F (2007)
Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells
Diagn Cytopathol, 35 (2), 80-4
DOI 10.1002/dc.20588, PubMed 17230566

Dong HP, Holth A, Berner A, Davidson B, Risberg B (2007)
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls
Cytometry B Clin Cytom, 72 (5), 332-43
DOI 10.1002/cyto.b.20172, PubMed 17226863

Gilliam AD, Davidson B, Guest J (2007)
The carbon footprint of laparoscopic surgery: should we offset?
Surg Endosc, 22 (2), 573
DOI 10.1007/s00464-007-9722-x, PubMed 18095020

Kleinberg L, Flørenes VA, Nesland JM, Davidson B (2007)
Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions
Am J Clin Pathol, 128 (3), 389-97
DOI 10.1309/E899BG1282M5D505, PubMed 17709312

Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007)
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
Cancer, 109 (2), 228-38
DOI 10.1002/cncr.22426, PubMed 17167759

Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B (2007)
The diagnostic role of claudins in serous effusions
Am J Clin Pathol, 127 (6), 928-37
DOI 10.1309/V025QRN3R9CJGNPX, PubMed 17509990

Kleinberg L, Lie AK, Flørenes VA, Nesland JM, Davidson B (2007)
Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma
Hum Pathol, 38 (7), 986-994
DOI 10.1016/j.humpath.2006.12.013, PubMed 17350081

Salani R, Davidson B, Fiegl M, Marth C, Müller-Holzner E, Gastl G, Huang HY, Hsiao JC, Lin HS, Wang TL, Lin BL, Shih IeM (2007)
Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions
Clin Cancer Res, 13 (19), 5805-9
DOI 10.1158/1078-0432.CCR-07-0853, PubMed 17908972

Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman SM (2007)
Molecular based treatment of oral cancer (Retraction of vol 39, pg 749, 2003)
Oral Oncol., 43 (4), 421
DOI 10.1016/j.oraloncology.2007.01.004

Publications 2006

Bassarova AV, Nesland JM, Davidson B (2006)
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions
Am J Surg Pathol, 30 (7), 878-82
DOI 10.1097/01.pas.0000208280.29291.34, PubMed 16819331

Berner A, Sigstad E, Pradhan M, Grøholt KK, Davidson B (2006)
Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals
Diagn Cytopathol, 34 (2), 97-100
DOI 10.1002/dc.20384, PubMed 16514672

Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006)
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
Clin Cancer Res, 12 (3 Pt 1), 791-9
DOI 10.1158/1078-0432.CCR-05-2516, PubMed 16467090

Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R (2006)
The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma
Gynecol Oncol, 102 (3), 453-61
DOI 10.1016/j.ygyno.2006.01.034, PubMed 16494928

Davidson B, Risberg B, Berner A, Bedrossian CW, Reich R (2006)
The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma
Semin Diagn Pathol, 23 (1), 35-43
DOI 10.1053/j.semdp.2006.06.003, PubMed 17044194

Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R (2006)
Heparanase expression correlates with poor survival in metastatic ovarian carcinoma
Gynecol Oncol, 104 (2), 311-9
DOI 10.1016/j.ygyno.2006.08.045, PubMed 17030350

Davidson B, Trope' CG, Wang TL, Shih IeM (2006)
Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival
Gynecol Oncol, 103 (3), 814-9
DOI 10.1016/j.ygyno.2006.05.042, PubMed 16844205

Davidson B, Zhang Z, Kleinberg L, Li M, Flørenes VA, Wang TL, Shih IeM (2006)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma
Clin Cancer Res, 12 (20 Pt 1), 5944-50
DOI 10.1158/1078-0432.CCR-06-1059, PubMed 17062665

Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, Davidson B, Risberg B (2006)
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
Am J Clin Pathol, 125 (3), 451-8
DOI 10.1309/15B66DQMFYYM78CJ, PubMed 16613351

Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R (2006)
Expression of E-cadherin transcriptional regulators in ovarian carcinoma
Virchows Arch, 449 (5), 520-8
DOI 10.1007/s00428-006-0274-6, PubMed 17024425

Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R (2006)
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
Gynecol Oncol, 103 (3), 831-40
DOI 10.1016/j.ygyno.2006.06.042, PubMed 16919315

Gotlieb WH, Bruchim I, Ben-Baruch G, Davidson B, Zeltser A, Andersen A, Olsen H (2006)
Doxorubicin levels in the serum and ascites of patients with ovarian cancer
Eur J Surg Oncol, 33 (2), 213-5
DOI 10.1016/j.ejso.2006.11.006, PubMed 17174514

Jørgensen K, Davidson B, Flørenes VA (2006)
Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma
Mod Pathol, 19 (11), 1446-55
DOI 10.1038/modpathol.3800662, PubMed 16951673

Kleinberg L, Flørenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, Nesland JM, Shih IeM, Davidson B (2006)
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma
Virchows Arch, 449 (1), 31-9
DOI 10.1007/s00428-005-0144-7, PubMed 16541284

Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih IeM, Wang TL (2006)
Homozygous deletion of MKK4 in ovarian serous carcinoma
Cancer Biol Ther, 5 (6), 630-4
DOI 10.4161/cbt.5.6.2675, PubMed 16627982

Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang TL, Shih IeM (2006)
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival
Proc Natl Acad Sci U S A, 103 (49), 18739-44
DOI 10.1073/pnas.0604083103, PubMed 17130457

Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM, Wang TL (2006)
Notch3 gene amplification in ovarian cancer
Cancer Res, 66 (12), 6312-8
DOI 10.1158/0008-5472.CAN-05-3610, PubMed 16778208

Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M (2006)
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma
Hum Pathol, 37 (5), 562-8
DOI 10.1016/j.humpath.2005.12.016, PubMed 16647954

Sivertsen S, Berner A, Michael CW, Bedrossian C, Davidson B (2006)
Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions
Acta Cytol, 50 (6), 603-7
DOI 10.1159/000326027, PubMed 17152269

Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R, Davidson B (2006)
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression
Lung Cancer, 54 (3), 309-17
DOI 10.1016/j.lungcan.2006.08.010, PubMed 16996643

Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B (2006)
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570

Publications 2005

Chen YC, Davidson B, Cheng CC, Maitra A, Giuntoli RL, Hruban RH, Wang TL, Shih IeM (2005)
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma
Biochim Biophys Acta, 1730 (2), 96-102
DOI 10.1016/j.bbaexp.2005.06.008, PubMed 16084606

Chen YC, Pohl G, Wang TL, Morin PJ, Risberg B, Kristensen GB, Yu A, Davidson B, Shih IeM (2005)
Apolipoprotein E is required for cell proliferation and survival in ovarian cancer
Cancer Res, 65 (1), 331-7
PubMed 15665311

Davidson B, Abeler VM (2005)
Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature
Diagn Cytopathol, 32 (5), 307-9
DOI 10.1002/dc.20245, PubMed 15830366

Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM (2005)
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Gynecol Oncol, 96 (1), 42-7
DOI 10.1016/j.ygyno.2004.09.049, PubMed 15589578

Davidson B, Vintman L, Nielsen S, Reich R, Berner A (2005)
Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma--a new model for the study of tumor biology and disease progression
Lung Cancer, 49 Suppl 1, S89-93
DOI 10.1016/j.lungcan.2005.03.026, PubMed 15950809

Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F (2005)
Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions
Am J Clin Pathol, 123 (3), 360-8
DOI 10.1309/PTBB-5BPC-KX8K-9V69, PubMed 15716231

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005)
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
Cancer, 103 (8), 1631-43
DOI 10.1002/cncr.20946, PubMed 15742334

Givant-Horwitz V, Davidson B, Reich R (2005)
Laminin-induced signaling in tumor cells
Cancer Lett, 223 (1), 1-10
DOI 10.1016/j.canlet.2004.08.030, PubMed 15890231

Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B (2005)
Angiogenic molecule expression is downregulated in effusions from breast cancer patients
Breast Cancer Res Treat, 94 (1), 71-80
DOI 10.1007/s10549-005-7328-3, PubMed 16142438

Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B (2005)
Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities
Diagn Cytopathol, 33 (5), 332-7
DOI 10.1002/dc.20296, PubMed 16240397

Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, Berner A, Goldberg I, Givant-Horwitz V, Tropè CG, Kristensen GB, Nesland JM, Børresen-Dale AL (2005)
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
Mol Cancer, 4, 26
DOI 10.1186/1476-4598-4-26, PubMed 16042759

Shih IeM, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE, Vang R, Parmigiani G, Kurman RJ, Trope CG, Davidson B, Wang TL (2005)
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
Proc Natl Acad Sci U S A, 102 (39), 14004-9
DOI 10.1073/pnas.0504195102, PubMed 16172393

Sigstad E, Dong HP, Nielsen S, Berner A, Davidson B, Risberg B (2005)
Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping
Diagn Cytopathol, 33 (5), 325-31
DOI 10.1002/dc.20282, PubMed 16240402

Slipicevic A, Holm R, Nguyen MT, Bøhler PJ, Davidson B, Flørenes VA (2005)
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome
Am J Clin Pathol, 124 (4), 528-36
DOI 10.1309/YT58WWMTA6YR1PRV, PubMed 16146807

Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B (2005)
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
Cancer, 103 (11), 2313-9
DOI 10.1002/cncr.21031, PubMed 15844177

Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A (2005)
Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling
J Clin Oncol, 23 (9), 1927-33 (Retracted)
DOI 10.1200/JCO.2005.03.172, PubMed 15774785

Vintman L, Nielsen S, Berner A, Reich R, Davidson B (2005)
Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells
Cancer, 103 (11), 2427-33
DOI 10.1002/cncr.21014, PubMed 15830375

Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B (2005)
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317

Publications 2004

Davidson B (2004)
Malignant effusions: from diagnosis to biology
Diagn Cytopathol, 31 (4), 246-54
DOI 10.1002/dc.20133, PubMed 15452897

Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004)
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Cancer, 100 (10), 2139-47
DOI 10.1002/cncr.20219, PubMed 15139056

Davidson B, Goldberg I, Tell L, Vigdorchik S, Baekelandt M, Berner A, Kristensen GB, Reich R, Kopolovic J (2004)
The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions
Clin Exp Metastasis, 21 (3), 191-9
DOI 10.1023/b:clin.0000037703.37275.35, PubMed 15387369

Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R (2004)
Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression
Clin Cancer Res, 10 (21), 7335-46
DOI 10.1158/1078-0432.CCR-04-0183, PubMed 15534110

Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM (2004)
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma
Breast Cancer Res Treat, 83 (2), 119-28
DOI 10.1023/B:BREA.0000010704.17479.8a, PubMed 14997042

Davidson B, Reich R, Lazarovici P, Flørenes VA, Risberg B, Nielsen S, Sert B, Bedrossian C (2004)
Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma
Lung Cancer, 44 (2), 159-65
DOI 10.1016/j.lungcan.2003.11.014, PubMed 15084380

Davidson B, Suo Z, Nesland JM (2004)
Malignant mesothelioma
Ultrastruct Pathol, 28 (4), 179-80
DOI 10.1080/01913120490518051, PubMed 15693629

Davidson B, Vintman L, Zcharia E, Bedrossian C, Berner A, Nielsen S, Ilan N, Vlodavsky I, Reich R (2004)
Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma
Clin Exp Metastasis, 21 (5), 469-76
DOI 10.1007/s10585-004-3150-2, PubMed 15672872

Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B (2004)
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome
Am J Clin Pathol, 122 (3), 412-20
DOI 10.1309/CHFH-EYAT-44WW-P7J3, PubMed 15362372

Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R (2004)
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma
Gynecol Oncol, 93 (2), 517-23
DOI 10.1016/j.ygyno.2004.03.009, PubMed 15099972

Givant-Horwitz V, Davidson B, Reich R (2004)
Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor
Cancer Res, 64 (10), 3572-9
DOI 10.1158/0008-5472.CAN-03-3424, PubMed 15150114

Posadas EM, Davidson B, Kohn EC (2004)
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature
Curr Opin Oncol, 16 (5), 478-84
DOI 10.1097/00001622-200409000-00012, PubMed 15314519

Sigstad E, Dong HP, Davidson B, Berner A, Tierens A, Risberg B (2004)
The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in referred fine-needle aspiration specimens
Diagn Cytopathol, 31 (3), 159-63
DOI 10.1002/dc.20108, PubMed 15349984

Stevens EV, Posadas EM, Davidson B, Kohn EC (2004)
Proteomics in cancer
Ann Oncol, 15 Suppl 4, iv167-71
DOI 10.1093/annonc/mdh922, PubMed 15477302

Xi Z, Kaern J, Davidson B, Klokk TI, Risberg B, Tropé C, Saatcioglu F (2004)
Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer
Gynecol Oncol, 94 (1), 80-5
DOI 10.1016/j.ygyno.2004.03.044, PubMed 15262123

Publications 2003

Berner A, Davidson B, Sigstad E, Risberg B (2003)
Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions
Diagn Cytopathol, 29 (6), 344-8
DOI 10.1002/dc.10372, PubMed 14648793

Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R (2003)
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
Clin Exp Metastasis, 20 (7), 621-31
DOI 10.1023/a:1027347932543, PubMed 14669793

Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R (2003)
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
Clin Exp Metastasis, 20 (2), 161-9
DOI 10.1023/a:1022696012668, PubMed 12705637

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R (2003)
PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma
Clin Cancer Res, 9 (4), 1412-9
PubMed 12684413

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R (2003)
Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
Cancer Metastasis Rev, 22 (1), 103-15
DOI 10.1023/a:1022272204045, PubMed 12716042

Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope' CG, Risberg B, Kopolovic J (2003)
AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients
Gynecol Oncol, 90 (2), 248-57
DOI 10.1016/s0090-8258(03)00321-4, PubMed 12893184

Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA (2003)
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma
Clin Cancer Res, 9 (6), 2248-59
PubMed 12796393

Davidson B, Risberg B, Reich R, Berner A (2003)
Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis
Clin Lab Med, 23 (3), 729-54, viii
DOI 10.1016/s0272-2712(03)00058-1, PubMed 14560537

Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, Reich R (2003)
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
Gynecol Oncol, 91 (1), 160-72
DOI 10.1016/s0090-8258(03)00434-7, PubMed 14529677

Givant-Horwitz V, Davidson B, van de Putte G, Dong HP, Goldberg I, Amir S, Kristensen GB, Reich R (2003)
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma
Clin Exp Metastasis, 20 (7), 599-609
DOI 10.1023/a:1027340208536, PubMed 14669791

Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM (2003)
Molecular based treatment of oral cancer
Oral Oncol, 39 (8), 749-58 (Retracted)
DOI 10.1016/s1368-8375(03)00098-8, PubMed 13679198

Publications 2002

Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B (2002)
Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases
Am J Clin Pathol, 118 (1), 85-92
DOI 10.1309/M877-QABM-D9GB-FJAX, PubMed 12109861

Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R (2002)
Caveolin-1 expression in ovarian carcinoma is MDR1 independent
Am J Clin Pathol, 117 (2), 225-34
DOI 10.1309/u40r-1bn4-6kj3-bdg3, PubMed 11863219

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R (2002)
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma
Mol Cell Endocrinol, 187 (1-2), 39-45
DOI 10.1016/s0303-7207(01)00709-2, PubMed 11988310

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I (2002)
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
Clin Exp Metastasis, 19 (2), 135-44
DOI 10.1023/a:1014582911680, PubMed 11964077

Davidson B, Reich R, Risberg B, Nesland JM (2002)
The biological role and regulation of matrix metalloproteinases (MMP) in cancer
Arkh Patol, 64 (3), 47-53
PubMed 15338725

Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM (2002)
Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma
Int J Surg Pathol, 10 (3), 175-80
DOI 10.1177/106689690201000302, PubMed 12232570

Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG (2002)
Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications
Int J Gynecol Pathol, 21 (2), 155-60
DOI 10.1097/00004347-200204000-00008, PubMed 11917225

Ustün M, Berner A, Davidson B, Risberg B (2002)
Fine-needle aspiration cytology of lobular carcinoma in situ
Diagn Cytopathol, 27 (1), 22-6
DOI 10.1002/dc.10128, PubMed 12112810

Ustün M, Risberg B, Davidson B, Berner A (2002)
Cystic change in metastatic lymph nodes: a common diagnostic pitfall in fine-needle aspiration cytology
Diagn Cytopathol, 27 (6), 387-92
DOI 10.1002/dc.10201, PubMed 12451573

Publications 2001

Amitay R, Nass D, Meitar D, Goldberg I, Davidson B, Trakhtenbrot L, Brok-Simoni F, Ben-Ze'ev A, Rechavi G, Kaufmann Y (2001)
Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma
Am J Pathol, 159 (1), 43-9
DOI 10.1016/S0002-9440(10)61671-9, PubMed 11438452

Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G (2001)
Infertility treatment after conservative management of borderline ovarian tumors
Cancer, 92 (2), 320-5
DOI 10.1002/1097-0142(20010715)92:2<320::aid-cncr1325>3.0.co;2-g, PubMed 11466685

Davidson B (2001)
Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature
Anal Cell Pathol, 23 (3-4), 107-28
DOI 10.1155/2001/418547, PubMed 12082292

Davidson B (2001)
Ovarian carcinoma and serous effusions: a patho-biological study
Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 011165863, ISBN 82-7633-155-6

Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R (2001)
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions
Am J Clin Pathol, 115 (4), 517-24
DOI 10.1309/B1YX-L8DB-TGY1-7905, PubMed 11293899

Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R (2001)
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients
Clin Cancer Res, 7 (11), 3457-64
PubMed 11705863

Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R (2001)
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study
Gynecol Oncol, 81 (2), 166-71
DOI 10.1006/gyno.2001.6156, PubMed 11330944

Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P (2001)
The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells
Am J Surg Pathol, 25 (11), 1405-12
DOI 10.1097/00000478-200111000-00008, PubMed 11684957

Davidson B, Reich R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, Kristensen GB, Trope CG, Bryne M, Kopolovic J, Nesland JM (2001)
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
Eur J Cancer, 37 (16), 2040-9
DOI 10.1016/s0959-8049(01)00235-0, PubMed 11597382

Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM (2001)
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma
Clin Cancer Res, 7 (3), 551-7
PubMed 11297247

Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA (2001)
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
Gynecol Oncol, 83 (2), 249-56
DOI 10.1006/gyno.2001.6388, PubMed 11606079

Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, Kristensen GB, Bryne M, Reich R (2001)
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome
Am J Surg Pathol, 25 (12), 1493-500
DOI 10.1097/00000478-200112000-00004, PubMed 11717538

Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J (2001)
Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma
Clin Cancer Res, 7 (12), 4073-9
PubMed 11751504

Gotlieb WH, Goldberg I, Weisz B, Davidson B, Novikov I, Kopolovic J, Ben-Baruch G (2001)
Topoisomerase II immunostaining as a prognostic marker for survival in ovarian cancer
Gynecol Oncol, 82 (1), 99-104
DOI 10.1006/gyno.2001.6208, PubMed 11426969

Risberg B, Davidson B, Nielsen S, Dong HP, Christensen J, Johansen P, Asschenfeldt P, Berner A (2001)
Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry
Diagn Cytopathol, 25 (4), 214-9
DOI 10.1002/dc.2041, PubMed 11599103

Publications 2000

Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM (2000)
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications
Clin Exp Metastasis, 18 (2), 197-202
DOI 10.1023/a:1006711320107, PubMed 11235996

Berner HS, Davidson B, Berner A, Risberg B, Nesland JM (2000)
Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions
Virchows Arch, 436 (4), 330-5
DOI 10.1007/s004280050455, PubMed 10834535

Cohen ZR, Knoller N, Hadani M, Davidson B, Nass D, Ram Z (2000)
Traumatic intratumoral hemorrhage as the presenting symptom of a spinal neurinoma. Case report
J Neurosurg, 93 (2 Suppl), 327-9
DOI 10.3171/spi.2000.93.2.0327, PubMed 11012070

Davidson B, Berner A (2000)
[Serous effusions]
Tidsskr Nor Laegeforen, 120 (3), 367-72
PubMed 10827531

Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V (2000)
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
J Pathol, 192 (4), 460-9
DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M, PubMed 11113863

Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M (2000)
Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions
Hum Pathol, 31 (9), 1081-7
DOI 10.1053/hupa.2000.9776, PubMed 11014575

Davidson B, Goldberg I, Kopolovic J, Gotlieb WH, Givant-Horwitz V, Nesland JM, Berner A, Ben-Baruch G, Bryne M, Reich R (2000)
Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study
Clin Exp Metastasis, 18 (6), 501-7
DOI 10.1023/a:1011858225144, PubMed 11592307

Davidson B, Goldberg I, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (2000)
Expression of topoisomerase II and Ki-67 in cervical carcinoma--clinicopathological study using immunohistochemistry
APMIS, 108 (3), 209-15
DOI 10.1034/j.1600-0463.2000.d01-46.x, PubMed 10752690

Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M (2000)
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study
Gynecol Oncol, 77 (1), 35-43
DOI 10.1006/gyno.1999.5708, PubMed 10739688

Davidson B, Gotlieb WH, Ben-Baruch G, Nesland JM, Bryne M, Goldberg I, Kopolovic J, Berner A (2000)
E-Cadherin complex protein expression and survival in ovarian carcinoma
Gynecol Oncol, 79 (3), 362-71
DOI 10.1006/gyno.2000.5964, PubMed 11104606

Gotlieb WH, Soriano D, Achiron R, Zalel Y, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (2000)
CA 125 measurement and ultrasonography in borderline tumors of the ovary
Am J Obstet Gynecol, 183 (3), 541-6
DOI 10.1067/mob.2000.105940, PubMed 10992171

Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000)
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings
J Clin Pathol, 53 (7), 513-7
DOI 10.1136/jcp.53.7.513, PubMed 10961174

Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK (2000)
The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation
Transplantation, 70 (10), 1454-8
DOI 10.1097/00007890-200011270-00010, PubMed 11118089

Publications 1999

Barker P, Campbell P, Davidson B (1999)
From the ashes of experience: reflections on madness survival and growth
Whurr publishers, London, 192 s.
BIBSYS 040599426, ISBN 1-86156-120-2

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Berner A, Bryne M, Reich R (1999)
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
Clin Exp Metastasis, 17 (10), 799-808
DOI 10.1023/a:1006723011835, PubMed 11089877

Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, Novikov I, Kopolovic J (1999)
Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma--clinicopathologic correlation
Acta Obstet Gynecol Scand, 78 (3), 240-4
PubMed 10078587

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R (1999)
MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
Gynecol Oncol, 73 (3), 372-82
DOI 10.1006/gyno.1999.5381, PubMed 10366463

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R (1999)
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
Gynecol Oncol, 72 (3), 380-6
DOI 10.1006/gyno.1998.5285, PubMed 10053110

Davidson B, Risberg B, Berner A, Smeland EB, Torlakovic E (1999)
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction
Diagn Mol Pathol, 8 (4), 183-8
DOI 10.1097/00019606-199912000-00003, PubMed 10617274

Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, Berner A (1999)
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers
Virchows Arch, 435 (1), 43-9
DOI 10.1007/s004280050393, PubMed 10431845

Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J (1999)
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis
J Clin Pathol, 52 (3), 198-202
DOI 10.1136/jcp.52.3.198, PubMed 10450179

Stratton R, Bryce K, Beynon H, Tibballs J, Watkinson A, Davidson B (1999)
Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosus
J R Soc Med, 92 (12), 636-7
DOI 10.1177/014107689909201209, PubMed 10692887

Warwick RJ, Davidson B, Watkinson A (1999)
Successful use of a covered nitinol self-expanding stent to seal a malignant fistula of the common bile duct
Clin Radiol, 54 (6), 410-2
DOI 10.1053/crad.1999.0050, PubMed 10406346

Publications 1998

Barker PJ, Davidson B (1998)
Psychiatric nursing: ethical strife
Arnold, London, XVIII, 359 s.
BIBSYS 960847499, ISBN 0-340-62523-6

Barshack I, Goldberg I, Davidson B, Ravid A, Schiby G, Kopolovic J, Leviav A, Friedman E (1998)
Expression of rasGTPase activating protein in basal cell carcinoma of the skin
Mod Pathol, 11 (3), 271-5
PubMed 9521474

Davidson B, Agulansky L, Goldberg I, Friedman E, Ramon J, Barshack I, Kopolovic J (1998)
Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer
Pathol Res Pract, 194 (6), 399-404
DOI 10.1016/S0344-0338(98)80030-7, PubMed 9689648

Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
Eur J Gynaecol Oncol, 19 (1), 46-9
PubMed 9476059

Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry
Eur J Obstet Gynecol Reprod Biol, 76 (1), 109-14
DOI 10.1016/s0301-2115(97)00161-9, PubMed 9481557

Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Kopolovic J (1998)
Ulex Europaeus lectin and anti-CD31 staining in squamous cell carcinoma of the uterine cervix: potential prognostic markers
Int J Gynecol Pathol, 17 (3), 205-10
DOI 10.1097/00004347-199807000-00003, PubMed 9656115

Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R (1998)
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix
Int J Gynecol Pathol, 17 (4), 295-301
DOI 10.1097/00004347-199810000-00002, PubMed 9785129

Goldberg I, Davidson B, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (1998)
Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study
J Clin Pathol, 51 (10), 781-5
DOI 10.1136/jcp.51.10.781, PubMed 10023343

Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G (1998)
Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome
Cancer, 82 (1), 141-6
PubMed 9428490

Gotlieb WH, Friedman E, Bar-Sade RB, Kruglikova A, Hirsh-Yechezkel G, Modan B, Inbar M, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (1998)
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
J Natl Cancer Inst, 90 (13), 995-1000
DOI 10.1093/jnci/90.13.995, PubMed 9665148

Publications 1997

Davidson B, Goldberg I, Kopolovic J (1997)
Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix
Pathol Res Pract, 193 (7), 491-5
DOI 10.1016/s0344-0338(97)80102-1, PubMed 9342755

Davidson B, Goldberg I, Kopolovic J (1997)
Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
Int J Gynecol Pathol, 16 (4), 335-8
DOI 10.1097/00004347-199710000-00007, PubMed 9421072

Davidson B, Nass D (1997)
[Genetic defects in neurodegenerative diseases]
Harefuah, 132 (7), 481-5
PubMed 9153920

Salai M, Zemmer D, Segal E, Corat A, Heyman Z, Davidson B, Langevitz P, Livneh A (1997)
Chronic massive knee effusion in familial Mediterranean fever
Semin Arthritis Rheum, 27 (3), 169-72
DOI 10.1016/s0049-0172(97)80016-9, PubMed 9431588

Publications 1995

Davidson B, Kopolovic J (1995)
[Molecular biology of human papilloma virus infection of the female genital tract]
Harefuah, 129 (10), 417-20
PubMed 8647548